These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25496207)

  • 1. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.
    Thabit AK; Crandon JL; Nicolau DP
    Expert Opin Pharmacother; 2015 Feb; 16(2):159-77. PubMed ID: 25496207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic burden of antimicrobial resistance.
    Maragakis LL; Perencevich EN; Cosgrove SE
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bugs versus drugs: addressing the pharmacist's challenge.
    Burgess DS; Rapp RP
    Am J Health Syst Pharm; 2008 May; 65(9 Suppl 2):S4-15. PubMed ID: 18436737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of antimicrobial resistance.
    Virk A; Steckelberg JM
    Mayo Clin Proc; 2000 Feb; 75(2):200-14. PubMed ID: 10683663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extended spectrum beta lactamase forming pathogens (ESBL)].
    Gastmeier P
    Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):592-3. PubMed ID: 23138656
    [No Abstract]   [Full Text] [Related]  

  • 8. Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient.
    DeRyke CA; Maglio D; Nicolau DP
    Expert Opin Pharmacother; 2005 Jun; 6(6):873-89. PubMed ID: 15952918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of resistant microbes in critical care units is transient, despite an unrestricted formulary and multiple antibiotic trials.
    Franklin GA; Moore KB; Snyder JW; Polk HC; Cheadle WG
    Surg Infect (Larchmt); 2002; 3(2):135-44. PubMed ID: 12519480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.
    Iosifidis E; Antachopoulos C; Tsivitanidou M; Katragkou A; Farmaki E; Tsiakou M; Kyriazi T; Sofianou D; Roilides E
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):615-22. PubMed ID: 18624668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
    Kunz AN; Brook I
    Chemotherapy; 2010; 56(6):492-500. PubMed ID: 21099222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiresistant Gram-negative infections: a global perspective.
    Ho J; Tambyah PA; Paterson DL
    Curr Opin Infect Dis; 2010 Dec; 23(6):546-53. PubMed ID: 20802331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gram-negative antibiotic resistance: there is a price to pay.
    Slama TG
    Crit Care; 2008; 12 Suppl 4(Suppl 4):S4. PubMed ID: 18495061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.
    Boyd N; Nailor MD
    Pharmacotherapy; 2011 Nov; 31(11):1073-84. PubMed ID: 22026395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of antibiotic resistance in the intensive care unit setting.
    Petrosillo N; Capone A; Di Bella S; Taglietti F
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections, bacterial resistance, and antimicrobial stewardship: the emerging role of hospitalists.
    Rosenberg DJ
    J Hosp Med; 2012; 7 Suppl 1():S34-43. PubMed ID: 23737336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections, bacterial resistance, and antimicrobial stewardship: the emerging role of hospitalists.
    Rosenberg DJ
    J Hosp Med; 2012; 7 Suppl 1():S34-43. PubMed ID: 23677633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.